9 Reasons Why Alan Greenspan Is Wrong About Everything
Former Federal Reserve Chairman Alan Greenspan recently laid out nine reasons the economy stinks. Here’s why he’s wrong, according to New York Life’s John Kim.
12 Best & Worst Broker-Dealers: Q2 Earnings, 2014
Some of Wall Street’s major players still struggle with litigation expenses; many are finding ways to further boost their wealth results.
Wall Street's Next Political Storm
Think the fading memory of the financial crisis means Big Finance will take less political heat in the 2016 presidential elections? Think again.
New Hire Roundup: Prudential Names Ward Head of Stable Value
In other new hires, HighTower announced that Kimberly Hollenbeck will join the firm as executive director of business development.
Alexandra Lebenthal: Who Are You Calling a Socialite?
The Lebenthal Holdings CEO on her new wealth unit, how she bought back her iconic family name from Merrill and how she recruits female advisors.
Bob Rodriguez Warns of Fiscal Nightmare Unless GOP Takes Senate
FPA's Bob Rodriguez warns that America’s fiscal fuse is nearing its end unless U.S. voters stage a revolt in midterm elections.
LPL, Cetera Reshuffle Leadership
Independent broker-dealer LPL Financial says Chief Marketing Officer Joan Khoury is leaving the firm and that two executives will step into new roles within its Advisor & Institution Solutions Group. Mimi Bock will become managing director for Client Experience and Training, taking over responsibilities previously handled by Khoury, while Ryan...
Cetera Advisors Names New President
Erinn Ford's appointment comes one week after Valerie Brown left Cetera Financial and Larry Roth was named head of its IBD operations.
Roth Replaces RCAP’s Brown as Schorsch Defends Move
Schorsch tells ThinkAdvisor that he adamantly denies allegations that RCAP is turning into an "ole boys' club" as the respected Valerie Brown leaves Cetera.
Nicholas Schorsch, the Mission of a Man: The 2014 IA 25 Profile
Believe it or not, it’s been less than a year since real estate investor Nicholas Schorsch started making headlines for his IBD buys.